Main Library
With the value-based care (VBC) market predicted to grow to $43.4 billion by 2031, this healthcare model continues to gain momentum, prioritizing patient-centered, outcome-focused approaches. Personalized care addresses the shortcomings of traditional fee-for-service models, which have long prioritized treatment volume over patient outcomes, further driving up costs while often failing to improve long-term patient health. In fact, recent reports from 2024 indicate that over 50% of Medicare beneficiaries are enrolled in Medicare Advantage plans that align with VBC frameworks, resulting in a 25% increase in provider participation in VBC implementation last year.
In the face of VBC implementation challenges such as operational complexity, technological demands, and financial risk, some adopters of this model reported measurable successes. Humana, for example, had 30% fewer inpatient admissions in 2022 among its VBC patient population compared to those who were members of traditional Medicare, saving over 200,000 admissions.
One approach to navigating these challenges when implementing personalized care is by starting with specialized populations, allowing organizations to test, learn, and refine their approach. This focus helps manage transition risks while addressing the personalized needs of certain groups, including those traditionally underserved in healthcare.